| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000035366 |
| Receipt No. | R000040302 |
| Scientific Title | Study for inhibitory effect on increase in postprandial blood glucose level by ingestion of dry sprout |
| Date of disclosure of the study information | 2018/12/26 |
| Last modified on | 2019/03/27 (Ver. 5) |
| Basic information | ||
| Public title | Study for inhibitory effect on increase in postprandial blood glucose level by ingestion of dry sprout | |
| Acronym | Study for inhibitory effect on increase in postprandial blood glucose level by ingestion of sprout | |
| Scientific Title | Study for inhibitory effect on increase in postprandial blood glucose level by ingestion of dry sprout | |
| Scientific Title:Acronym | Study for inhibitory effect on increase in postprandial blood glucose level by ingestion of sprout | |
| Region |
|
|
| Condition | ||
| Condition | Healthy Adults | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To verify inhibitory effect on increase in postprandial blood glucose level by ingesting dry sprout. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Time course of blood glucose concentration changes before and after ingesting of dry sprout or test food(C, Cmax, Tmax, deltaAUC)
*Measure at before ingestion and 30, 60, 90, and 120 minutes after ingestion. |
| Key secondary outcomes | Time course of blood insulin concentration changes before and after ingesting of dry sprout and test food(C, Cmax, Tmax, deltaAUC)
*Measure at just before ingestion and 30, 60, 90, and 120 minutes after ingestion. Blood penicidine concentration Physical examination (body weight, blood pressure, pulse rate, BMI) Questionnaire for subject background, excise and meal at the previous day, and physical condition and meal at the test day. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Subjects ingest any one of A to C test food once a day. After about one week washout, subjects ingest another test food once a day. After a further week washout, subjects ingest the other test food once a day.
Test food A : Dry sprout 4.3 g, Rice 150 g, Retort curry 180 g Test food B : Control dry sprout 4.3 g, Rice 150 g, Retort curry 180 g Test food C : Rice 150 g, Retort curry 180 g Test food A > (about one week) > Test food B > (about one week) > Test food C |
|
| Interventions/Control_2 | Test food B > (about one week) > Test food C > (about one week) > Test food A | |
| Interventions/Control_3 | Test food C > (about one week) > Test food A > (about one week) > Test food B | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1. Healthy Japanese women over 20 years old and under 65 at the time of consent acquisition
2. Those whose BMI less than 25 at the time of screening 3. Those whose blood glucose concentration is less than 126 mg/dL at the time of screening 4. Those whose blood HbA1c is less than 6.5% at the time of screening 5. Those who apply to 4 and are top 30 of numerical value of HbA1c. |
|||
| Key exclusion criteria | 1. Those who have a chronic disease and are undergoing medication, those with a serious disease history
2. Those who are allergic to the test food 3. Those who regularly use medicines, specific insurance foods, health foods, etc. that may affect blood glucose levels 4. Those who have participated in other tests within the first month before the start of the exam, or who are planning to participate in other exams after this exam consent 5. Those who are judged ineligible at the discretion of the examining supervisor and research leader 6. Those who are breast-feeding, pregnant, and are planning or hoping pregnancy during the exam |
|||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Healthcare Systems Co., Ltd. | ||||||
| Division name | Research and Development Department | ||||||
| Zip code | |||||||
| Address | Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN | ||||||
| TEL | 03-6809-2722 | ||||||
| masudat@hc-sys.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Healthcare Systems Co., Ltd. | ||||||
| Division name | Research and Development Department | ||||||
| Zip code | |||||||
| Address | Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN | ||||||
| TEL | 03-6809-2722 | ||||||
| Homepage URL | |||||||
| masudat@hc-sys.jp | |||||||
| Sponsor | |
| Institute | Healthcare Systems Co., Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Saladcosmo Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040302 |